Department of Clinical and Movement Neurosciences (F84) Genetic and acquired neuromuscular diseases represent a major cause of mortality and morbidity in children and adults with a prevalence of more than 5% in the general population. Currently there is a large gap between major basic science discoveries and patient benefit in these important disorders. In order to reduce this gap we form the first truly multidisciplinary translational research centre into these disabling diseases. Our mission is to translate basic science findings into clinical trials and new treatments for children and adults with disabling neuromuscular diseases. The Department of Clinical and Movement Neurosciences is based at the UCL Institute of Neurology in collaboration with the UCL Institute of Child Health, other departments of UCL and at the University of Newcastle Upon Tyne. There is a very large adult and paediatric patient populations with neuromuscular diseases cared for at the co-located hospitals: The National Hospital for Neurology and Neurosurgery (NHNN), UCLH Foundation Trust; Great Ormond Street NHS Trust, and the Newcastle teaching hospitals. FOR ALL QUERIES PLEASE USE THE CONTACT TABS FOUND IN EACH OF THE INDIVIDUAL COURSES/CONFERENCES AND PRODUCTS, PLEASE ONLY CONTACT THE ONLINE STORE DIRECTLY IF YOU ARE EXPERIENCING PAYMENT DIFFICULTIES.
Department of Clinical and Movement Neurosciences (F84)F84 The 5th Queen Square Movement Disorders Short CourseDescriptionThe course is designed for neurologists, neurology trainees, and movement disorders enthusiasts from other neuroscience specialties, from the UK, Europe and worldwide.
F84 UCL Queen Square Movement Disorders Centre SymposiumDescriptionThe UCL Queen Square Movement Disorders Centre is a research centre that translates discoveries in movement disorders into clinical benefit at UCL/UCLH. The centre harnesses our faculty of world-leading researchers and clinicians, supported by state of the art facilities and international collaborations to lead discovery research and experimental medicine programmes in order to make the next key breakthroughs for Parkinson’s disease and other movement disorders.
We are delighted to host our second symposium which will welcome a range of international and local speakers, in addition to UCL early career and senior clinical academics to discuss recent discoveries and promising pathways for a better understanding and treatment of movement disorders. Attendees will hear about developments across the translational research spectrum, from genetics, molecular and cellular biology, biomarkers, and epidemiology to experimental medicine. The symposium will provide a platform for the exchange of ideas between clinician and academics from different disciplines, highlight promising pathways for research translation, and facilitate new collaborations.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
London's global university
Managed by UCL Finance University College London - Gower Street - London - WC1E 6BT Email: [email protected]
© UCL 1999–2012, UCL is a Company Incorporated by Royal Charter (England/Wales), number: RC000631 VAT number: GB 524 3711 68
